Tag Archives: Rituxan

FDA approves first biosimilar to Roche cancer drug Rituxan

(Reuters) – Celltrion Inc’s Truxima on Wednesday became the first biosimilar to Roche Holding AG’s $ 7-billion-per-year cancer drug Rituxan to be approved in the United States to treat non-Hodgkin’s lymphoma. FILE PHOTO: The logo of Celltrion is seen at company’s headquarters in Incheon, South Korea, October 28, 2016. REUTERS/Kim Hong-Ji The approval by the… Read More »